LHDX Lucira Health

Lucira Health to Participate in LifeSci Partners HealthTech Symposium

Lucira Health to Participate in LifeSci Partners HealthTech Symposium

EMERYVILLE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, and a digital health platform that will connect patients with providers, today announced that the company will participate in the LifeSci Partners HealthTech Symposium on September 21st, 2022, at 10:30am ET. A live and archived webcast of the event can be accessed through the of the Lucira website.

About Lucira Health

Lucira is a medical technology company focused on the development and commercialization of innovative infectious disease tests to make lab-quality diagnostics more accessible. Lucira designed its test platform to provide accurate, reliable, PCR-quality test results anywhere and at any time. Beyond its already commercialized COVID-19 and COVID-19 & Flu Tests, Lucira is working on new diagnostic tests for respiratory infections and other categories including women’s health and sexually transmitted infections (STIs). For more information, visit

Investor Contact

Greg Chodaczek



332-895-3230



EN
07/09/2022

Underlying

LHDXLucira Health

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lucira Health

 PRESS RELEASE
Free
LHDX LUCIRA HEALTH

Lucira Health Announces U.S. Launch of First & Only At-Home Combinatio...

Lucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale Process Combination Test Also Secures Point-Of-Care Authorization in Australia Lab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to access time-sensitive prescription treatment optionsLucira’s COVID-19 & Flu Home Test demonstrated similar performance for COVID-19 and Flu in head-to-head comparison study with highly sensitive lab-based PCR testsLucira...

March 28, 2023 1 EN
 PRESS RELEASE
Free
LHDX LUCIRA HEALTH

Lucira Health Announces FDA Authorization of First & Only At-Home Comb...

Lucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy Filing Test Delivers Lab-Quality Performance with Results in 30 Minutes or Less – The First At-Home Test to Ever Include Flu Lab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to access time-sensitive prescription treatment optionsLucira’s COVID-19 & Flu Home Test demonstrated similar performance for COVID-19, Flu A and...

February 27, 2023 1 EN
 PRESS RELEASE
Free
LHDX LUCIRA HEALTH

Lucira Health to Pursue Strategic Sale of its Business Through Volunta...

Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process No debtor-in-possession financing required as the Company intends to fund operations and the sale process with available cash on hand. EMERYVILLE, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company, announced today that it has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. The Company further disclosed that it i...

February 22, 2023 1 EN
 PRESS RELEASE
Free
LHDX LUCIRA HEALTH

Lucira Health Launches Lucira Connect, a Free Test-to-Treat Telehealth...

Lucira Health Launches Lucira Connect, a Free Test-to-Treat Telehealth Service for Covid-19 or Flu in Canada For $98 CAD Canadians will receive a free telehealth appointment included with purchase of a testLucira Connect provides lab-quality at-home test-users a telehealth visit at no additional cost, enabling Test-to-Treatment within hours for only the cost of the test, excluding prescription costs.Lucira partners with Medi-Call to give users who test positive for Covid-19 or Flu the option to access a virtual telehealth consultation to discuss their risk factors and appropriate treatment ...

January 4, 2023 1 EN
 PRESS RELEASE
Free
LHDX LUCIRA HEALTH

Lucira Health Submits EUA for Over-The-Counter (OTC) Use of its COVID-...

Lucira Health Submits EUA for Over-The-Counter (OTC) Use of its COVID-19 & Flu Test EMERYVILLE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health" or "Lucira"), a medical technology company, announced that it submitted an Emergency Use Authorization application to the FDA for OTC use of its simple, at-home molecular COVID-19 & Flu test. Lucira’s test for COVID-19 & Flu was granted Emergency Use Authorization for Point-of-Care (POC) use in a healthcare setting in November 2022. In seeking OTC authorization, Lucira intends to make the test broadly ...

January 3, 2023 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch